Clinical Trial Update: Effect of Panax Ginseng on the Cognitive Performance in Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating Panax ginseng for cognitive performance in Alzheimer's disease has completed. The snippet does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Panax Ginseng (Panax ginseng)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Alzheimer's Disease, Memory Decline | Phase 1, Phase 2 | Status: COMPLETED